NCT02327845Active, not recruiting
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Source: ClinicalTrials.gov · Last updated 15 Jun 2026
Brief summary (registry, in English)
The goals of this study are: (1) to better understand the relationship between the phenotype and genotype of amyotrophic lateral sclerosis (ALS) and related diseases, including primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), progressive muscular atrophy (PMA), and frontotemporal dementia (FTD); and (2) to develop biomarkers that might be useful in aiding therapy development for this group of disorders.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 708 (actual)
- First submitted
- 24 Dec 2014
- Start date
- Apr 2015
- Primary completion date
- Jul 2031
- Lead sponsor
- University of Miami
- NCT number
- NCT02327845
What you commit to
- Study type: Observational
- Participants enrolled: 708
- From Apr 2015 to the primary completion date, Jul 2031
- 15 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Affected with end or late stage disease.
- A condition or situation which, in the PI's opinion, could confound the study finding or may interfere significantly with the individual's participation and compliance with the study protocol. This includes (but is not limited to) neurological, psychological and/or medical conditions.
Who the study is looking for
- Member of at least one of the following categories:
- Individuals with a clinical diagnosis of ALS or a related disorder, including FTD, HSP, PLS, PMA and MSP (sporadic or familial).
- Family member of an enrolled affected individual.
- Able and willing to comply with relevant procedures.
Sex: All · Accepts healthy volunteers
Sites (15)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Eberhard Karls University of Tübingen Coordinator of this site? Confirm its status | Tübingen | Germany | Unknown status |
| University of Virginia (UVA) Coordinator of this site? Confirm its status | Charlottesville | United States | Unknown status |
| Cleveland Clinic Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
| University of Texas Southwestern (UTSW) Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
| University of Iowa Coordinator of this site? Confirm its status | Iowa City | United States | Unknown status |
| Kansas University Medical Center (KUMC) Coordinator of this site? Confirm its status | Kansas City | United States | Unknown status |
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
| Twin Cities ALS Research Consortium Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
| Stanford University Coordinator of this site? Confirm its status | Palo Alto | United States | Unknown status |
| University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| University of Texas Health Science Center San Antonio (UTHSCSA) Coordinator of this site? Confirm its status | San Antonio | United States | Unknown status |
| University of California, San Diego (UCSD) Coordinator of this site? Confirm its status | San Diego | United States | Unknown status |
| California Pacific Medical Center (CPMC) Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
| Wake Forest University Coordinator of this site? Confirm its status | Winston-Salem | United States | Unknown status |
| University of Cape Town Coordinator of this site? Confirm its status | Cape Town | South Africa | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.